|3rd December 2018
What was your life like aged 28? What were you doing? What were your plans? At 28, I was developing my career, thinking about marriage, considering buying a house and generally ‘finding my place in the world.’
Now imagine your life being thrown into a tailspin because you’ve been told you have a degenerative neurological condition for which there is no cure. Imagine receiving this diagnosis and nobody can give you a prognosis to say how quickly your disease will progress or which bodily functions will be affected.
On top of that, imagine that you’re faced with a “black hole” of information and support. You’re sent away with no guidance or signposting as to what you should be doing next, what services you might need, or where you can go for reliable information to make important decisions that could affect the rest of your life.
"Industry is also providing a better platform to educate, whether that’s through medical information or through enabling patients to share their own experiences"
That was me in 2008 when I was diagnosed with multiple sclerosis. I felt completely disengaged from the healthcare system.
Fast-forward ten years and not only have I seen progress in terms of treatment options, research priorities, the value of shared-decision making and self-care, and the strength of the patient voice. I’m now better informed, better connected and have become a highly experienced patient advocate and patient engagement champion.
One of the biggest hurdles I faced post-diagnosis was that I didn’t know what was out there. Over the years, once I’d discovered the NHS patient charter, organisations like the MS Society, the MS Trust and MS-UK, and I’d connected with peer-to-peer support, whether in person, online via social media or through networks like Shift.ms, I gained access to a wealth of information that has really helped me.
However, life would have been much easier if I’d been signposted to these organisations at the time of diagnosis. Unfortunately, I still hear of patients being diagnosed and sent away with no information or guidance.
Once diagnosed, there needs to be channels through which patients can receive reliable and up-to-date information so that they’re able to manage their condition as effectively as possible. The paternalistic model of healthcare is changing rapidly, and the MS space is no exception.
As a patient, I want to know that I can have a two-way conversation with my healthcare team and that I will be respected and encouraged to have an active and informed role in my care. When I was diagnosed by a general neurologist this didn’t happen. It only began to happen after I switched to an MS specialist neurologist who is a patient engagement champion.
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?